Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Loss of myocyte enhancer factor 2 expression in osteoclasts leads to opposing skeletal phenotypes

Bone(2020)10.1016/j.bone.2020.115466Source: DataRank Database

Loss of myocyte enhancer factor 2 expression in osteoclasts leads to opposing skeletal phenotypes is a research paper published in Bone (2020). On theSindex it has a DataRank of 0. It has been cited 19 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access19 citations

Download PDF

Cite:

Linked data & code

gen hpa doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.81)OA: greenTopics (57)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Andrew Norton,Anqi Zhang,Conrado Aparicio ORCID,Hari Prasad,Rajaram Gopalakrishnan

Live enrichment

PubMed:32512162 PMC:PMC7443313 OpenAlex:https://openalex.org/W3033289226

NIAMS NIH HHS

Grant: R01 AR061352

NIAMS NIH HHS

Grant: T32 AR050938

National Institutes of Health

Grant: 5T32AR050938-05

Musculoskeletal Training Grant

National Institutes of Health

Grant: 5R01AR061352-02

Role of HDAC7 in Osteoclast Differentiation

National Institutes of Health

National Institute of Arthritis and Musculoskeletal and Skin Diseases

FWCI

0.81

Citation Percentile

0.7%

Citation Trend

2021

2022

2023

2024

2025

2026

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7443313

publisherhttps://api.elsevier.com/content/article/PII:S8756328220302465?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S8756328220302465?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.bone.2020.115466

Fields of Study

Bone Metabolism and DiseasesBone health and treatmentsMicroRNA in disease regulation0301 basic medicine0303 health sciences03 medical and health sciencesAnimalsBone and BonesCell DifferentiationFemaleMEF2 Transcription FactorsMaleMiceOsteoclastsOsteogenesisPhenotypeRANK Ligand

MeSH Terms

AnimalsBone and BonesCell DifferentiationFemaleMaleOsteoclastsOsteogenesisPhenotypeMiceRANK LigandMEF2 Transcription Factors

Keywords

Mef2OsteoclastRANKLTranscription factorBiologyCell biologyPhenotypeOsteoblastEnhancerCellular differentiationConditional gene knockoutIn vitroGeneGeneticsActivator (genetics)EstrogenTranscription factorsOsteoclastsSex SpecificHdacsMaleMEF2 Transcription FactorsRANK LigandCell DifferentiationBone and BonesMiceOsteogenesisAnimalsFemale

Sustainable Development Goals

SDG 0: Good health and well-being

Loss of myocyte enhancer factor 2 expression in osteoclasts leads to opposing skeletal phenotypes

FAIR Checklist

Authors (8)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)